The antidepressant fluvoxamine shows promise in preventing people infected with coronavirus from developing serious symptoms and having to be hospitalized, according to a nonrandomized study of California racetrack workers.
Caline Mattar, MD, assistant professor of medicine, infectious diseases helps with study of fluvoxamine; may help COVID patients avoid serious illness
View Content